Excitatory amino acids stimulate inositol phospholipid hydrolysis and reduce proliferation in cultured astrocytes. 1990

F Nicoletti, and G Magrì, and F Ingrao, and V Bruno, and M V Catania, and P Dell'Albani, and D F Condorelli, and R Avola
Institutes of Biochemistry, University of Catania, Italy.

Excitatory amino acids stimulated inositol phospholipid hydrolysis in primary cultures of astrocytes, as reflected by an increased formation of [3H]inositol monophosphate [( 3H]InsP) in the presence of 10 mM Li+. Quisqualate was the most potent activator of inositol phospholipid hydrolysis, followed by glutamate and ibotenate. Kainate exhibited low activity, whereas N-methyl-D-aspartate (NMDA) and alpha-amino-3-hydroxy-5-methylisoxazolepropionate (AMPA) were inactive. The increase in [3H]InsP formation induced by glutamate was potentiated after 12-h exposure to the proliferative agent epidermal growth factor (EGF), suggesting that activation of the mitotic cycle leads to an enhanced coupling of glutamate recognition sites with phospholipase C. To study how glutamate receptors are involved in regulating cell proliferation, we have measured [methyl-3H]thymidine incorporation in cultured astrocytes. Excitatory amino acids reduced thymidine incorporation with a pharmacological profile similar to that observed for the stimulation of inositol phospholipid hydrolysis. Quisqualate acted as a potent antiproliferative agent, both under basal conditions and in cells stimulated to proliferate by addition of EGF or phorbol 12-tetradecanoate 13-acetate. Glutamate and ibotenate reduced [methyl-3H]thymidine incorporation at high concentrations, whereas kainate, AMPA, and NMDA were virtually inactive. The action of quisqualate on both inositol phospholipid hydrolysis and thymidine incorporation was attenuated by 2-amino-4-phosphonobutyrate, which acted as a weak agonist/competitive antagonist. Other excitatory amino acid receptor antagonists were not effective.(ABSTRACT TRUNCATED AT 250 WORDS)

UI MeSH Term Description Entries
D007294 Inositol An isomer of glucose that has traditionally been considered to be a B vitamin although it has an uncertain status as a vitamin and a deficiency syndrome has not been identified in man. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1379) Inositol phospholipids are important in signal transduction. Myoinositol,Chiro-Inositol,Mesoinositol,Chiro Inositol
D007700 Kinetics The rate dynamics in chemical or physical systems.
D010069 Oxadiazoles Compounds containing five-membered heteroaromatic rings containing two carbons, two nitrogens, and one oxygen atom which exist in various regioisomeric forms. Oxadiazole
D010743 Phospholipids Lipids containing one or more phosphate groups, particularly those derived from either glycerol (phosphoglycerides see GLYCEROPHOSPHOLIPIDS) or sphingosine (SPHINGOLIPIDS). They are polar lipids that are of great importance for the structure and function of cell membranes and are the most abundant of membrane lipids, although not stored in large amounts in the system. Phosphatides,Phospholipid
D011519 Proto-Oncogenes Normal cellular genes homologous to viral oncogenes. The products of proto-oncogenes are important regulators of biological processes and appear to be involved in the events that serve to maintain the ordered procession through the cell cycle. Proto-oncogenes have names of the form c-onc. Proto-Oncogene,Proto Oncogene,Proto Oncogenes
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D004815 Epidermal Growth Factor A 6-kDa polypeptide growth factor initially discovered in mouse submaxillary glands. Human epidermal growth factor was originally isolated from urine based on its ability to inhibit gastric secretion and called urogastrone. Epidermal growth factor exerts a wide variety of biological effects including the promotion of proliferation and differentiation of mesenchymal and EPITHELIAL CELLS. It is synthesized as a transmembrane protein which can be cleaved to release a soluble active form. EGF,Epidermal Growth Factor-Urogastrone,Urogastrone,Human Urinary Gastric Inhibitor,beta-Urogastrone,Growth Factor, Epidermal,Growth Factor-Urogastrone, Epidermal,beta Urogastrone
D006868 Hydrolysis The process of cleaving a chemical compound by the addition of a molecule of water.
D000596 Amino Acids Organic compounds that generally contain an amino (-NH2) and a carboxyl (-COOH) group. Twenty alpha-amino acids are the subunits which are polymerized to form proteins. Amino Acid,Acid, Amino,Acids, Amino

Related Publications

F Nicoletti, and G Magrì, and F Ingrao, and V Bruno, and M V Catania, and P Dell'Albani, and D F Condorelli, and R Avola
July 1987, Life sciences,
F Nicoletti, and G Magrì, and F Ingrao, and V Bruno, and M V Catania, and P Dell'Albani, and D F Condorelli, and R Avola
February 1989, Biochemical pharmacology,
F Nicoletti, and G Magrì, and F Ingrao, and V Bruno, and M V Catania, and P Dell'Albani, and D F Condorelli, and R Avola
February 1986, European journal of pharmacology,
F Nicoletti, and G Magrì, and F Ingrao, and V Bruno, and M V Catania, and P Dell'Albani, and D F Condorelli, and R Avola
December 1987, Brain research,
F Nicoletti, and G Magrì, and F Ingrao, and V Bruno, and M V Catania, and P Dell'Albani, and D F Condorelli, and R Avola
October 1989, FEBS letters,
F Nicoletti, and G Magrì, and F Ingrao, and V Bruno, and M V Catania, and P Dell'Albani, and D F Condorelli, and R Avola
January 1990, Cellular signalling,
F Nicoletti, and G Magrì, and F Ingrao, and V Bruno, and M V Catania, and P Dell'Albani, and D F Condorelli, and R Avola
September 1989, Journal of neurochemistry,
F Nicoletti, and G Magrì, and F Ingrao, and V Bruno, and M V Catania, and P Dell'Albani, and D F Condorelli, and R Avola
February 1996, Journal of neurochemistry,
F Nicoletti, and G Magrì, and F Ingrao, and V Bruno, and M V Catania, and P Dell'Albani, and D F Condorelli, and R Avola
January 1989, Neuroscience,
F Nicoletti, and G Magrì, and F Ingrao, and V Bruno, and M V Catania, and P Dell'Albani, and D F Condorelli, and R Avola
December 1989, Journal of neurochemistry,
Copied contents to your clipboard!